Skip to content

Camber Launches Eslicarbazepine Acetate Tablets

Eslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.

PISCTWAY, N.J. – Camber Pharmaceuticals announces the addition of Eslicarbazepine Acetate Tablets to its portfolio.

Eslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.

Eslicarbazepine Acetate Tablets are available in:

  • 200 mg, 400 mg, and 800 mg strengths in 30-count bottles
  • 600 mg strength in a 60-count bottle

To find out more information on Eslicarbazepine Acetate Tablets, visit: www.camberpharma.com/eslicarbazepine

Comments

Latest